Congress Lecture

0.0The average rating is 0 stars out of 5.

Is the Use of Growth Factors and Stem Cells a Key to Long-term Success?

Merete Aaboe

Guided bone regeneration procedures normally require the use of autogenous bone harvested from the intraoral area or, in the case of larger bone defects, from the iliac crest. Wherever the bone is harvested, there is a potential risk of morbidity at the donor site. This provides an argument for using alternative procedures or materials.

Growth factors either produced as recombinant growth factors or extracted from the patient are available on the market, and their use is recommended before or simultaneously with implant placement. Treatment of cancer with stem cells has been known since the early 1960s. Today extensive ongoing research focuses on the potential of stem cells to create new tissues or organs.

The lecture, on the basis of the existing literature, clarifies whether the use of growth factors or stem cells has a potential effect on the final outcome of implant therapy. 

At the end of this Congress Lecture you should be able to…

  • recognize various sources for harvesting stem cells
  • describe the processes involved in tissue engineering for bone augmentation
  • discuss if and/or when growth factors and stem cells should be used in connection with implant therapy  
Duration
15 minutes
Source
ITI Online Academy Recordings, Basel, Switzerland, 2017
CPD/CME
0.27 hours
Purchase price
8 Academy Coins
Publication date: Jul 3, 2018 Last review date: Jun 26, 2018 Next review date: Jun 26, 2021
  • Autogenous Bone Block
  • Autogenous Bone Chips
  • Biomaterials
  • Bone Augmentation
  • Bone Management
  • Components & Materials
  • Congress Lecture
  • English
  • GBR
  • Languages
  • Long-Term Data
  • Outcomes
  • Surgery
  • Surgical Planning & Procedures

ITI QR code Mvc

Share this page

Download the QR code with a link to this page and use it in your presentations or share it on social media.

Download QR code
QR code